TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Cantor Fitzgerald Reiterates Overweight Rating on TG Therapeutics (TGTX)

March 3, 2025 1:07 PM EST

Cantor Fitzgerald analyst Prakhar Agrawal reiterated an Overweight rating on TG Therapeutics (NASDAQ: TGTX).

The analyst comments "TGTX stock is up >18% (XBI: -1%) on the back of positive comments on the 4Q call around 1Q trends for Briumvi (anti-CD20 drug in... More